UK – First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%

New real-world data from the UK has found a significant decrease in COVID-19 infections among healthcare workers who have received the first dose of the Pfizer/BioNTech vaccine.

The data, analysed by Public Health England (PHE), shows that one dose of the Pfizer/BioNTech vaccine reduces the risk of infection by more than 70%, and by 95% after the second dose is administered.

In addition, PHE’s analysis of routine testing data showed that, in people aged 80 years and over, one dose of the vaccine is 57% effective against symptomatic COVID-19 disease.

On top of that, early data also suggests that a second dose of the Pfizer/BioNTech jab in over 80s increases protection against symptomatic COVID-19 to over 85%…